Evidence map›Paper›PMID 41984261›Full record

ArticleBiotechnology letters2026

Purification, biochemical characterization and structural analysis of uricase produced from a new strain of Streptomyces.

Anand Kumar Dakuri, Girijasankar Guntuku, Swathi Nageswara, Sowjanya Gurugubelli, Jagadeesh Chiluvuru

Abstract read
PubMed Publisher
In one paragraph

Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anand Kumar DakuriAndhra University College of Pharmaceutical Sciences, Andhra University, Vishakhapatnam, Andhra Pradesh, 530003, India. anandkumar.dakuri@gmail.com.ORCID http://orcid.org/0009-0004-6657-8910
Girijasankar GuntukuAndhra University College of Pharmaceutical Sciences, Andhra University, Vishakhapatnam, Andhra Pradesh, 530003, India.
Swathi NageswaraJNTU-GV College of Pharmaceutical Sciences, JNTU-GV, Vizianagaram, 535003, Andhra Pradesh, India.
Sowjanya GurugubelliAditya Pharmacy College, Surampalem, Kakinada, Andhra Pradesh, 533437, India.
Jagadeesh ChiluvuruVignan's Institute of Engineering for Women (A), Vishakhapatnam, Andhra Pradesh, 530049, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The isolate A85 was identified as Streptomyces enissocaesilis, and it might serve as a novel actinobacteria source for uricase production. The uricase was successfully produced and purified from this novel strain, demonstrating that it could be an efficient source for future applications. Characterization studies of the purified enzyme showed maximal activity at pH 9 and 37 °C. From the differential scanning calorimetry, a melting point of 55.6 °C was observed, which ensured that the purified uricase is thermostable. Overall, 32 fold purification with a 48% yield of uricase was recovered at the end of purification steps. Inhibitor studies revealed that the purified uricase is metalloprotease. V

Indexed as

Bacterial ProteinsStreptomycesUrate OxidaseAmino Acid SequenceEnzyme StabilityHydrogen-Ion ConcentrationKineticsMolecular WeightProtein Structure, SecondarySpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBacterial ProteinsUrate OxidaseDockingMALDI-TOF MSPDBsumSecondary structureStreptomyces enissocaesilisUricase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.